Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2014

01-11-2014 | Editorial

What Should We Tell Our Patients About E-cigarettes?

Authors: Lori A. Bastian, MD, MPH, Cheryl Oncken, MD

Published in: Journal of General Internal Medicine | Issue 11/2014

Login to get access

Excerpt

An electronic cigarette (e-cigarette) is a battery-powered device that uses heat to vaporize a solution (often nicotine in propylene glycol and/or glycerol). E-cigarettes are popular, available in many flavors, and can be purchased in convenience stores and on-line.1 There are at least three categories of e-cigarette consumers: smokers who plan to continue smoking but want to use e-cigarettes when smoking is not allowed; smokers who plan to use the e-cigarette to assist them in quitting or cutting-down on smoking; and a minority of non-smokers who want to try something new (the concern is that this group will include minors). Although there are several public health concerns associated with e-cigarettes, we will highlight the issues most salient to the conversations general internists might have with their patients who smoke. …
Literature
1.
go back to reference King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever-use of electronic cigarettes among US Adults, 2010–2011. Nicotine Tob Res. 2013;15:1623–7.PubMedCrossRef King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever-use of electronic cigarettes among US Adults, 2010–2011. Nicotine Tob Res. 2013;15:1623–7.PubMedCrossRef
3.
5.
6.
go back to reference Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessations: a randomized controlled trial. Lancet. 2013;382:1629–37.PubMedCrossRef Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessations: a randomized controlled trial. Lancet. 2013;382:1629–37.PubMedCrossRef
7.
go back to reference Lee YO, Hebert CJ, Nonnemaker JM, Kim AE. Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med. 2014;62:14–9.PubMedCrossRef Lee YO, Hebert CJ, Nonnemaker JM, Kim AE. Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med. 2014;62:14–9.PubMedCrossRef
8.
go back to reference Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109:500–7.PubMedCrossRef Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109:500–7.PubMedCrossRef
9.
go back to reference Steinberg MB, Zimmermann MH, Delnevo CD, Lewis MJ, Shukla P, Coups EJ, Foulds J. E-cigarette vs. nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine. JGIM. 2014. doi:10.1007/s11606-014-2889-7.PubMed Steinberg MB, Zimmermann MH, Delnevo CD, Lewis MJ, Shukla P, Coups EJ, Foulds J. E-cigarette vs. nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine. JGIM. 2014. doi:10.​1007/​s11606-014-2889-7.PubMed
Metadata
Title
What Should We Tell Our Patients About E-cigarettes?
Authors
Lori A. Bastian, MD, MPH
Cheryl Oncken, MD
Publication date
01-11-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2943-5

Other articles of this Issue 11/2014

Journal of General Internal Medicine 11/2014 Go to the issue

Healing Arts

Up for Yes

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine